"The refusal of Warner-Lambert’s board to give due consideration to the Pfizer offer, and the coercive provisions of its agreement with AHP … effectively deny shareholders the right and opportunity to enhance their investments," – Alan G. Hevesi

“The refusal of Warner-Lambert’s board to give due consideration to the Pfizer offer, and the coercive provisions of its agreement with AHP … effectively deny shareholders the right and opportunity to enhance their investments,” – Alan G. Hevesi